Signaturefd LLC Cuts Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Signaturefd LLC decreased its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 40.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,199 shares of the health services provider’s stock after selling 798 shares during the quarter. Signaturefd LLC’s holdings in Teladoc Health were worth $26,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the company. ARK Investment Management LLC grew its holdings in shares of Teladoc Health by 4.5% during the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after buying an additional 912,692 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Teladoc Health by 37.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider’s stock valued at $28,807,000 after buying an additional 418,909 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Teladoc Health by 9.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 658,435 shares of the health services provider’s stock valued at $12,240,000 after buying an additional 57,989 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its holdings in shares of Teladoc Health by 49.4% during the third quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock valued at $8,437,000 after buying an additional 149,976 shares during the last quarter. Finally, Swiss National Bank grew its holdings in shares of Teladoc Health by 1.0% during the third quarter. Swiss National Bank now owns 359,802 shares of the health services provider’s stock valued at $6,689,000 after buying an additional 3,600 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on TDOC shares. TD Cowen dropped their target price on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a report on Friday, April 26th. Citigroup dropped their target price on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Barclays dropped their target price on shares of Teladoc Health from $25.00 to $20.00 and set an “overweight” rating on the stock in a report on Friday, April 26th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Friday, April 26th. Finally, Evercore ISI dropped their target price on shares of Teladoc Health from $15.00 to $14.00 and set an “in-line” rating on the stock in a report on Friday, April 26th. Twelve investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and an average target price of $18.73.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now owns 38,470 shares in the company, valued at approximately $579,358.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now owns 38,470 shares in the company, valued at approximately $579,358.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jason N. Gorevic sold 53,755 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the completion of the sale, the chief executive officer now owns 653,073 shares in the company, valued at approximately $9,482,619.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 138,368 shares of company stock worth $1,989,227. 0.95% of the stock is owned by corporate insiders.

Teladoc Health Stock Down 1.6 %

TDOC opened at $12.78 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.47 and a current ratio of 3.82. Teladoc Health, Inc. has a fifty-two week low of $12.53 and a fifty-two week high of $30.41. The firm’s fifty day moving average is $14.44 and its 200 day moving average is $17.57. The stock has a market cap of $2.17 billion, a price-to-earnings ratio of -9.16 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The firm had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter last year, the firm posted ($0.37) EPS. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, sell-side analysts forecast that Teladoc Health, Inc. will post -1.04 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.